PMC:7361216 / 4231-4439 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T53","span":{"begin":41,"end":44},"obj":"Body_part"},{"id":"T54","span":{"begin":62,"end":75},"obj":"Body_part"},{"id":"T55","span":{"begin":76,"end":82},"obj":"Body_part"}],"attributes":[{"id":"A53","pred":"fma_id","subj":"T53","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A54","pred":"fma_id","subj":"T54","obj":"http://purl.org/sig/ont/fma/fma19034"},{"id":"A55","pred":"fma_id","subj":"T55","obj":"http://purl.org/sig/ont/fma/fma62977"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T24","span":{"begin":62,"end":75},"obj":"Body_part"},{"id":"T25","span":{"begin":70,"end":75},"obj":"Body_part"},{"id":"T26","span":{"begin":76,"end":82},"obj":"Body_part"}],"attributes":[{"id":"A24","pred":"uberon_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/UBERON_0001322"},{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"},{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T61","span":{"begin":70,"end":75},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"},{"id":"T62","span":{"begin":90,"end":95},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T63","span":{"begin":96,"end":104},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9443"},{"id":"T64","span":{"begin":116,"end":122},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T30","span":{"begin":0,"end":5},"obj":"Chemical"},{"id":"T31","span":{"begin":185,"end":190},"obj":"Chemical"}],"attributes":[{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_137080"},{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_137080"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T10","span":{"begin":90,"end":95},"obj":"Species"},{"id":"T11","span":{"begin":96,"end":104},"obj":"Species"}],"attributes":[{"id":"A10","pred":"ncbi_taxonomy_id","subj":"T10","obj":"NCBItxid:9606"},{"id":"A11","pred":"ncbi_taxonomy_id","subj":"T11","obj":"NCBItxid:9443"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T26","span":{"begin":106,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T19","span":{"begin":62,"end":75},"obj":"Body_part"},{"id":"T20","span":{"begin":76,"end":82},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0001322"},{"id":"A20","pred":"uberon_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"113","span":{"begin":0,"end":5},"obj":"Chemical"},{"id":"104","span":{"begin":37,"end":40},"obj":"Gene"},{"id":"108","span":{"begin":50,"end":58},"obj":"Species"},{"id":"109","span":{"begin":90,"end":95},"obj":"Species"},{"id":"114","span":{"begin":185,"end":190},"obj":"Chemical"},{"id":"122","span":{"begin":195,"end":203},"obj":"Species"}],"attributes":[{"id":"A104","pred":"pubann:denotes","subj":"104","obj":"Gene:4099"},{"id":"A108","pred":"pubann:denotes","subj":"108","obj":"Tax:9606"},{"id":"A109","pred":"pubann:denotes","subj":"109","obj":"Tax:9606"},{"id":"A122","pred":"pubann:denotes","subj":"122","obj":"Tax:9606"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T49","span":{"begin":37,"end":40},"obj":"Protein"}],"attributes":[{"id":"A49","pred":"uniprot_id","subj":"T49","obj":"https://www.uniprot.org/uniprot/Q567S4"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T53","span":{"begin":41,"end":44},"obj":"Body_part"},{"id":"T54","span":{"begin":62,"end":75},"obj":"Body_part"},{"id":"T55","span":{"begin":76,"end":82},"obj":"Body_part"}],"attributes":[{"id":"A53","pred":"fma_id","subj":"T53","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A54","pred":"fma_id","subj":"T54","obj":"http://purl.org/sig/ont/fma/fma19034"},{"id":"A55","pred":"fma_id","subj":"T55","obj":"http://purl.org/sig/ont/fma/fma62977"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-sentences","denotations":[{"id":"T26","span":{"begin":106,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}

{"project":"LitCovid-PubTator","denotations":[{"id":"104","span":{"begin":37,"end":40},"obj":"Gene"},{"id":"108","span":{"begin":50,"end":58},"obj":"Species"},{"id":"109","span":{"begin":90,"end":95},"obj":"Species"},{"id":"113","span":{"begin":0,"end":5},"obj":"Chemical"},{"id":"114","span":{"begin":185,"end":190},"obj":"Chemical"},{"id":"122","span":{"begin":195,"end":203},"obj":"Species"}],"attributes":[{"id":"A104","pred":"tao:has_database_id","subj":"104","obj":"Gene:4099"},{"id":"A108","pred":"tao:has_database_id","subj":"108","obj":"Tax:9606"},{"id":"A109","pred":"tao:has_database_id","subj":"109","obj":"Tax:9606"},{"id":"A122","pred":"tao:has_database_id","subj":"122","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"PPSGG blocked the binding of an anti‐MAG IgM from patients to sciatic nerve myelin of non‐human primates. They also tested some of the pharmacokinetic and pharmacodynamic properties of PPSGG.\nIn patients suff"}